EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSORLG00000001602
Gene Symbol: DHCR24
4 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11a

Ensembl ID : ENSORLG00000018831
Gene Symbol: LOC101174330
3 Cross references
207 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4

Ensembl ID : ENSORLG00000000320
Gene Symbol: LOC101157953
4 Cross references
226 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4

Ensembl ID : ENSORLG00000009532
Gene Symbol: LOC101173089
4 Cross references
220 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSORLG00000017313
Gene Symbol: HMGCR
4 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase

Ensembl ID : ENSORLG00000002060
Gene Symbol: LOC101166888
4 Cross references
205 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2

Ensembl ID : ENSORLG00000023920
Gene Symbol: LOC101156869
4 Cross references
208 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSORLG00000007757
Gene Symbol: PDPK1B
4 Cross references
221 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSORLG00000012993
Gene Symbol: HPDB
4 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S10

Ensembl ID : ENSORLG00000007257
Gene Symbol: LOC105355366
4 Cross references
379 Possible Orthologues:

5'-Nucleotidase

Ensembl ID : ENSORLG00000014932
Gene Symbol: LOC101174549
4 Cross references
180 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSORLG00000017511
Gene Symbol: NT5E
4 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).